rdf-syntax-grammar
mods:
  schema location: http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
  title info:
    title: CNS Cancer
    sub title: Models, Markers, Prognostic Factors, Targets, and Therapeutic Approaches
  name:
    name part: Meir, Erwin G.
    role:
      role term: editor.
  name:
    name part: SpringerLink (Online service)
  type of resource: text
  origin info:
    place:
      place term: xxu
    date issued: 2009
    issuance: monographic
  language:
    language term: eng
  physical description:
    form: electronic
    form: electronic resource
    reformatting quality: access
    form: remote
    extent: XII, 1284 p. 160 illus., 64 illus. in color. With 2 16-page color inserts. online resource.
  abstract: CNS Cancer: Models, Markers, Prognostic Factors and Therapeutic Approaches Erwin G. Van Meir Cancers of the central nervous system are among the most lethal of human neoplasms. They are recalcitrant to even intensive multimodality therapies that include surgery, radiotherapy and chemotherapy. Moreover, especially in children, the consequences of these therapies can itself be devastating and involve serious cognitive and developmental disorders. It is small wonder that such cancers have come under the intense scrutiny of each of the subspecialties of clinical care and investigation as well as attracting some of the best basic research scientists. Their joint efforts are gradually peeling away the mysteries surrounding the genesis and progression of these tumors and inroads are being steadily made into understanding why they resist therapies.This makes it an especially opportune time to assemble some of the best investigators in the field to review the "state of the art" in the various arenas that comprise the assault on CNS tumors. While the lethality of these tumors has remained dismal over the past decades, there is finally real reason for optimism as our knowledge base grows exponentially larger. The major areas of this endeavor are displayed in CNS Cancer: Models, Markers, Prognostic Factors and Therapeutic Approaches. Each of the chapters in the book represents illustrative examples of the road from discovery through translation to clinical importance, although many begin the journey at different parts of this continuum. This includes several chapters on incredibly clever mouse models for deciphering the genetic wiring underlying the development of CNS tumors and how that wiring might be targeted for therapeutic benefit. A great deal of attention has been paid in the book to the development of genetic prognostic factors and biomarkers that could be used for assessing individual responses to therapies and so could lead to truly personalized medicine. Other possib…
  table of contents: Animal Models for Central Nervous Tumors -- Modeling Gliomas Using PDGF-Expressing Retroviruses -- Modeling Brain Tumors Using Avian Retroviral Gene Transfer -- Using Neurofibromatosis Type 1 Mouse Models to Understand Human Pediatric Low-Grade Gliomas -- Transgenic Mouse Models of CNS Tumors: Using Genetically Engineered Murine Models to Study the Role of p21-Ras in Glioblastoma Multiforme -- Pten-Deficient Mouse Models for High-Grade Astrocytomas -- The Nf1–/+; Trp53–/+cis Mouse Model of Anaplastic Astrocytoma and Secondary Glioblastoma: Dissecting Genetic Susceptibility to Brain Cancer -- Modeling Astrocytomas in a Family of Inducible Genetically Engineered Mice: Implications for Preclinical Cancer Drug Development -- Human Brain Tumor Cell and Tumor Tissue Transplantation Models -- Transformed Human Brain Cells in Culture as a Model for Brain Tumors -- Rat Glioma Models for Preclinical Evaluation of Novel Therapeutic and Diagnostic Modalities -- Neuro-oncogenesis Induced by Nitroso Compounds in Rodents and Strain-Specific Genetic Modifiers of Predisposition -- The Murine GL261 Glioma Experimental Model to Assess Novel Brain Tumor Treatments -- Spontaneous Occurrence of Brain Tumors in Animals: Opportunities as Preclinical Model Systems -- Prognostic Factors and Biomarkers -- p53 Pathway Alterations in Brain Tumors -- The PTEN/PI3 Kinase Pathway in Human Glioma -- Value of 1p/19q and Other LOH Markers for Brain Tumor Diagnosis, Prognosis, and Therapy -- Discovery of Genetic Markers for Brain Tumors by Comparative Genomic Hybridization -- Genomic Identification of Significant Targets in Brain Cancer -- Oncomodulatory Role of the Human Cytomegalovirus in Glioblastoma -- Aberrant EGFR Signaling in Glioma -- Mechanisms of Brain Tumor Angiogenesis -- Vaso-occlusive Mechanisms that Intiate Hypoxia and Necrosis in Glioblastoma: The Role of Thrombosis and Tissue Factor -- Transcription Profiling of Brain Tumors: Tumor Biology and Treatment Stratification -- Proteomic Pro…
  note: edited by Erwin G. Meir.
  subject:
    topic: Medicine
  subject:
    topic: Cancer research
  subject:
    topic: Pharmacology
  subject:
    topic: Oncology
  subject:
    topic: Biomedicine
  subject:
    topic: Cancer Research
  subject:
    topic: Pharmacology/Toxicology
  subject:
    topic: Oncology
  classification: RC261-271
  classification: 614.5999
  related item:
    title info:
      title: Springer eBooks
  related item:
    title info:
      title: Cancer Drug Discovery and Development
  identifier: 9781603275538
  identifier: http://dx.doi.org/10.1007/978-1-60327-553-8
  record info:
    record creation date: 100301
    record change date: 20151201021210.0
    record identifier: 978-1-60327-553-8